Randomised controlled trial for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats in General Practice in Italy: INFANT 2
Completed
- Conditions
- Information to physiciansNot ApplicablePhysician training
- Registration Number
- ISRCTN28525676
- Lead Sponsor
- Italian Drug Agency (Agenzia Italiana del Farmaco [AIFA])
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 900
Inclusion Criteria
All GPs are eligible, provided that their Local Health Authority has an organised system for tracking their prescriptions made within the Italian National Heath Service (NHS) till the 5th Anatomic Therapeutic Chemical (ATC) level, in order to evaluate these prescriptions and to provide doctors with feedback.
Exclusion Criteria
No exclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference (%) in NHS prescription of drugs under scrutiny (expressed as Defined Daily Dose [DDD] per thousand inhabitants/day), comparing those who have/ have not received the specific information.<br><br>Prescriptions within six months after the intervention will be evaluated.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the impact of pharmacist-led information meetings on physician prescribing behavior in general practice?
How do new information formats compare to traditional methods in improving physician adherence to prescribing guidelines?
What biomarkers or indicators predict the effectiveness of physician training on prescribing practices in primary care?
What adverse prescribing events are associated with physician training interventions in general practice?
Are there similar trials evaluating pharmacist-led interventions on prescribing in primary care settings?